Distinct role of outer membrane protein A in the intrinsic resistance of Acinetobacter baumannii and Acinetobacter nosocomialis.


Journal

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
ISSN: 1567-7257
Titre abrégé: Infect Genet Evol
Pays: Netherlands
ID NLM: 101084138

Informations de publication

Date de publication:
01 2019
Historique:
received: 28 10 2017
revised: 29 08 2018
accepted: 27 10 2018
pubmed: 6 11 2018
medline: 28 11 2019
entrez: 3 11 2018
Statut: ppublish

Résumé

Acinetobacter baumannii outer membrane protein A (AbOmpA) contributes to the intrinsic resistance of A. baumannii through the OmpA-like domain. The present study investigated the role of Acinetobacter nosocomialis OmpA (AnOmpA) in the intrinsic resistance of A. nosocomialis and compared it with the role of AbOmpA. The minimal inhibitory concentrations (MICs) of antimicrobial agents against wild-type A. nosocomialis ATCC 17903, ∆AnompA mutant, and single-copy AnompA-complemented strains were determined by performing E-test or agar dilution. Single-copy ompA cross-complemented strains were constructed by cross-inserting AnompA and AbompA open reading frames (ORFs) along with their native promoters into ∆AbompA and ∆AnompA mutant strains, respectively, and the MICs of antimicrobial agents against these strains were determined. The ∆AnompA mutant of A. nosocomialis was more susceptible to colistin (20.0-fold) and gentamicin (4.8-fold) than the wild-type strain. The MICs of gentamicin and tetracycline against the ∆AnompA mutant did not decrease in the presence of an efflux pump inhibitor. The MIC of trimethoprim against the ∆AnompA mutant harbouring P

Identifiants

pubmed: 30385392
pii: S1567-1348(18)30832-3
doi: 10.1016/j.meegid.2018.10.022
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Outer Membrane Proteins 0
OMPA outer membrane proteins 149024-69-1
Trimethoprim AN164J8Y0X

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

33-37

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Hyo Il Kwon (HI)

Department of Microbiology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.

Shukho Kim (S)

Department of Microbiology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.

Man Hwan Oh (MH)

Department of Nanobiomedical Science, Dankook University, Cheonan, Republic of Korea.

Minsang Shin (M)

Department of Microbiology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.

Je Chul Lee (JC)

Department of Microbiology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea. Electronic address: leejc@knu.ac.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH